Trial · NCT00623623
Trial comparisons27
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
1 to 20 of 27
Download this page as JSON| Comparison | Source |
|---|---|
| Tenecteplase (Group A) vs Primary PCI (Group B): Number of Patients With All Cause Death and Shock and CHF and Reinfarction and Disabling Stroke | Trial comparisons |
| Tenecteplase (Group A) vs Primary PCI (Group B): Number of Patients With All Cause Death and Shock | Trial comparisons |
| Tenecteplase (Group A) vs Primary PCI (Group B): Number of Patients With Ischaemic Stroke | Trial comparisons |
| Tenecteplase (Group A) vs Primary PCI (Group B): Number of Patients With Congestive Heart Failure (CHF) | Trial comparisons |
| Tenecteplase (Group A) vs Primary PCI (Group B): Number of Patients With Total Stroke (All Types) | Trial comparisons |
| Tenecteplase (Group A) vs Primary PCI (Group B): Number of Patients With Cardiogenic Shock | Trial comparisons |
| Tenecteplase (Group A) vs Primary PCI (Group B): Number of Patients With Major Non-intracranial Bleeds Including Blood Transfusions | Trial comparisons |
| Tenecteplase (Group A) vs Primary PCI (Group B): Number of Patients With Recurrent Myocardial Infarction (Reinfarction) | Trial comparisons |
| Tenecteplase (Group A) vs Primary PCI (Group B): Number of Patients With All Cause Death and Non-fatal Stroke | Trial comparisons |
| Tenecteplase (Group A) vs Primary PCI (Group B): Number of Patients With Serious Resuscitated Ventricular Fibrillation | Trial comparisons |
| Tenecteplase (Group A) vs Primary PCI (Group B): Number of Patients With Total Disabling Stroke | Trial comparisons |
| Tenecteplase (Group A) vs Primary PCI (Group B): Number of Patients With Intracranial Haemorrhage | Trial comparisons |
| Tenecteplase (Group A) vs Primary PCI (Group B): Number of Patients With All Cause Mortality | Trial comparisons |
| Tenecteplase (Group A) vs Primary PCI (Group B): Number of Patients With Total Non-intracranial Bleeds | Trial comparisons |
| Tenecteplase (Group A) vs Primary PCI (Group B): Number of Patients With Serious Repeat Target Vessel Revascularization | Trial comparisons |
| Tenecteplase (Group A) vs Primary PCI (Group B): Number of Patients With All Cause Death and Shock and Reinfarction | Trial comparisons |
| Tenecteplase (Group A) vs Primary PCI (Group B): Number of Patients With Rehospitalisation for Cardiac Reasons | Trial comparisons |
| Tenecteplase (Group A) vs Primary PCI (Group B): Number of Patients With Rehospitalisation for Non-cardiac Reasons | Trial comparisons |
| Tenecteplase (Group A) vs Primary PCI (Group B): Number of Patients With Serious Resuscitated Ventricular Fibrillation in Association With Invasive Procedures | Trial comparisons |
| Tenecteplase (Group A) vs Primary PCI (Group B): Number of Patients With Total Fatal Stroke | Trial comparisons |
trials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00623623/comparisons